1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow RFA: new trials by email Literature Review of RFA trials Research Report on RFA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tremelimumab With Chemoembolization or Ablation for Liver Cancer Tremelimumab, RFA, TACE - Heptocellular Cancer, Biliary Tract Neoplasms | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 61 | 2013-05-02 | 2019-12-10 |
Biliary Tract Neoplasms (1) · Carcinoma, Hepatocellular (1) · Liver Neoplasms (1)
National Cancer Institute (NCI) (1)
United States (1)